{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:24:24Z","timestamp":1790018664577,"version":"4.0.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.576658","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T06:55:16Z","timestamp":1603349716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Combined p14ARF and Interferon-\u03b2 Gene Transfer to the Human Melanoma Cell Line SK-MEL-147 Promotes Oncolysis and Immune Activation"],"prefix":"10.3389","volume":"11","author":[{"given":"Otto Luiz Dutra","family":"Cerqueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alejandra","family":"Clavijo-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Cristina","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharcisio","family":"Citrangulo Tortelli Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir Andrade","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alexandre M.","family":"Barbuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2249.2012.04657.x","article-title":"Suppression, subversion and escape: the role of regulatory T cells in cancer progression","volume":"171","author":"Oleinika","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/biomedicines4030018","article-title":"From benchtop to bedside: a review of oncolytic virotherapy","volume":"4","author":"Choi","year":"2016","journal-title":"Biomedicines"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00106","article-title":"Immune system, friend or foe of oncolytic virotherapy","volume":"7","author":"Filley","year":"2017","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat Rev Drug Discovery"},{"key":"B7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2007.02.002","article-title":"Oncolytic viruses in cancer therapy","volume":"254","author":"V\u00e4h\u00e4-Koskela","year":"2007","journal-title":"Cancer Lett"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1581528","DOI":"10.1080\/2162402X.2019.1596006","article-title":"Oncolytic viruses: how \u201clytic\u201d must they be for therapeutic efficacy","volume":"8","author":"Davola","year":"2019","journal-title":"Oncoimmunology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Different"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337corr1","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic Cell Death in Cancer Therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00866","article-title":"Oncolytic viral therapy and the immune system: a double-edged sword against cancer","volume":"9","author":"Marelli","year":"2018","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.11.006","article-title":"Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies","volume":"39","author":"Gujar","year":"2018","journal-title":"Trends Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.01.001","article-title":"Oncolytic Viruses and the Immune System: The Dynamic Duo","volume":"17","author":"Lemos de Matos","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.08.031","article-title":"Converting cold into hot tumors by combining immunotherapies","volume":"170","author":"Haanen","year":"2017","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13027","article-title":"Oncolytic virus therapy: A new era of cancer treatment at dawn","volume":"107","author":"Fukuhara","year":"2016","journal-title":"Cancer Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune Responses to Viral Gene Therapy Vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e479s","DOI":"10.6061\/clinics\/2018\/e479s","article-title":"Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer","volume":"73","author":"Strauss","year":"2018","journal-title":"Clinics (Sao Paulo Brazil)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19531","article-title":"Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy","volume":"8","author":"Medrano","year":"2017","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2784","DOI":"10.1038\/cddis.2017.201","article-title":"Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy","volume":"8","author":"Hunger","year":"2017","journal-title":"Cell Death Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"17017","DOI":"10.1038\/cddiscovery.2017.17","article-title":"Reestablishment of p53\/Arf and interferon-beta pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death","volume":"3","author":"Hunger","year":"2017","journal-title":"Cell Death Discov"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2016.09.011","article-title":"Intratumoral Immunization by p19Arf and Interferon-beta Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma","volume":"9","author":"Catani","year":"2016","journal-title":"Transl Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2001.0464","article-title":"Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models","volume":"4","author":"Qin","year":"2001","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10179","article-title":"TP53 mutations in human skin cancers","volume":"21","author":"Giglia-Mari","year":"2003","journal-title":"Hum Mutat"},{"key":"B27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/1471-2407-10-316","article-title":"Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6","volume":"10","author":"Merkel","year":"2010","journal-title":"BMC Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313830200","article-title":"Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines","volume":"279","author":"Sandoval","year":"2004","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature01850","article-title":"Integration of interferon-alpha\/beta signalling to p53 responses in tumour suppression and antiviral defence","volume":"424","author":"Takaoka","year":"2003","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206461","article-title":"The INK4a\/ARF locus and melanoma","volume":"22","author":"Sharpless","year":"2003","journal-title":"Oncogene"},{"key":"B31","article-title":"Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors","volume":"51","author":"James","year":"1991","journal-title":"Cancer Res"},{"key":"B32","article-title":"Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons","volume":"50","author":"Miyakoshi","year":"1990","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.10557","article-title":"Homozygous deletions within human chromosome band 9p21 in melanoma","volume":"89","author":"Fountain","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301453","article-title":"A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob","volume":"8","author":"Mizuguchi","year":"2001","journal-title":"Gene Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2006.04.032","article-title":"A rapid and efficient method for purification of recombinant adenovirus with arginine\u2013glycine\u2013aspartic acid-modified fibers","volume":"354","author":"Peng","year":"2006","journal-title":"Analyt Biochem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.139","article-title":"Induction of Oxidants Distinguishes Susceptibility of Prostate Carcinoma Cell Lines to p53 Gene Transfer Mediated by an Improved Adenoviral Vector","volume":"28","author":"Tamura","year":"2017","journal-title":"Hum Gene Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3351","article-title":"CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis","volume":"6","author":"Cerqueira","year":"2015","journal-title":"Oncotarget"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2013.23","article-title":"Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo","volume":"20","author":"Merkel","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41434-019-0071-x","article-title":"Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth","volume":"27","author":"Tamura","year":"2020","journal-title":"Gene Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jca.1032","article-title":"A new continuous-flow cell separation method based on cell density: principle, apparatus, and preliminary application to separation of human buffy coat","volume":"16","author":"Ito","year":"2001","journal-title":"J Clin Apher"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765201920190310","article-title":"In vitro generation of human monocyte-derived dendritic cells methodological aspects in a comprehensive review","volume":"91","author":"CECHIM","year":"2019","journal-title":"An Acad Bras Cienc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich\u2019s magic bullet concept: 100 years of progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0094","article-title":"Precision oncology: neither a silver bullet nor a dream","volume":"18","author":"S\u00e1nchez","year":"2017","journal-title":"Pharmacogenomics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nm.2385","article-title":"Caspase 3\u2013mediated stimulation of tumor cell repopulation during cancer radiotherapy","volume":"17","author":"Huang","year":"2011","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2000.4838","article-title":"Induction of apoptosis by cancer chemotherapy","volume":"256","author":"Kaufmann","year":"2000","journal-title":"Exp Cell Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1634\/theoncologist.11-4-342","article-title":"Chemotherapeutic approaches for targeting cell death pathways","volume":"11","author":"Ricci","year":"2006","journal-title":"Oncol"},{"key":"B49","first-page":"25","article-title":"Apoptosis: a gene-directed programme of cell death","volume":"26","author":"Alison","year":"1992","journal-title":"J R Coll Physicians London"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.172","article-title":"The clearance of dying cells: table for two","volume":"23","author":"Green","year":"2016","journal-title":"Cell Death Different"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000634","article-title":"Apoptotic cells activate the \u201cphoenix rising\u201d pathway to promote wound healing and tissue regeneration","volume":"3","author":"Li","year":"2010","journal-title":"Sci Signal"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1807-8","article-title":"Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy","volume":"65","author":"Medrano","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74826-y","article-title":"Response of human melanoma cell lines to interferon-beta genetransfer mediated by a modified adenoviral vector","author":"David","year":"2020","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","journal-title":"EMBO J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.3.925","article-title":"Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors","volume":"100","author":"Idzko","year":"2002","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.03.003","article-title":"Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells","volume":"38","author":"Ma","year":"2013","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101313","article-title":"Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing","volume":"188","author":"Simmons","year":"2012","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2891","article-title":"Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway","volume":"16","author":"Zitvogel","year":"2010","journal-title":"Clin Cancer Res  Off J Am Assoc Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh243","article-title":"Optimizing the exogenous antigen loading of monocyte-derived dendritic cells","volume":"17","author":"Dieckmann","year":"2005","journal-title":"Int Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00465-13","article-title":"Qualitative and Quantitative Analysis of Adenovirus Type 5 Vector-Induced Memory CD8 T Cells: Not as Bad as Their Reputation","volume":"87","author":"Steffensen","year":"2013","journal-title":"J Virol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.11.6497","article-title":"Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity","volume":"167","author":"Kemp","year":"2001","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4051","article-title":"Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients","volume":"22","author":"Gros","year":"2016","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ccell.2018.10.007","article-title":"PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8(+) T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients","volume":"34","author":"Naing","year":"2018","journal-title":"Cancer Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaci.2010.12.009","article-title":"Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17\/TH1 T-cell responses","volume":"127","author":"Hansel","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.82","article-title":"Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia","volume":"1","author":"Wemeau","year":"2010","journal-title":"Cell Death Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12252","article-title":"Human blood dendritic cell subsets exhibit discriminative pattern recognition receptor profiles","volume":"142","author":"Lundberg","year":"2014","journal-title":"Immunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.576658\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T06:55:19Z","timestamp":1603349719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.576658\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2020.576658"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.576658","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"article-number":"576658"}}